Raymond Hohl, MD, PhD, resigned as director of the Penn State Cancer Institute Nov. 21 — one day after Spotlight PA published a report detailing internal reviews that found issues related to the former leader’s care of patients and hostile…
The Latest
With financial pressures intensifying across healthcare, hospital and health system finance leaders are working closer with departmental and clinical leaders to help them understand the numbers behind care delivery. “It’s not about dumping spreadsheets; it’s about building a shared understanding…
Good Samaritan in Vincennes, Ind., has appointed Wendy Hernandez as chief administrative officer. Ms. Hernandez assumed the role as part of a leadership transition ahead of Adam Thacker moving into the president and CEO position in January, according to a…
John Whiteside has been appointed CEO of Merit Health River Oaks and Merit Health Woman’s Hospital in Flowood, Miss., effective Nov. 17. Mr. Whiteside brings more than 13 years of progressive healthcare leadership experience to the role, according to a…
Omaha, Neb.-based CHI Health appointed Julie Goebel as president of its Nebraska and Iowa market, overseeing 10 hospitals. Ms. Goebel stepped into the role after serving as interim market president for six months, overseeing CHI Health hospitals across Nebraska and…
The shuttered St. Louis-based Homer G. Phillips Memorial Hospital is set to reopen as Houston-based Nutex Health’s first micro-hospital in Missouri, Archview ER & Hospital. Homer G. Phillips Memorial Hospital’s board surrendered its license to the Missouri Department of Health…
Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 report from Bloomberg. About 93% of GLP-1 ads from telehealth…
On this episode, Matthew Cantonis, MBA, Senior Vice President and Chief Operating Officer of USF Tampa General Physicians joins the podcast to discuss how leadership culture drives improvements in patient access. He highlights the role of agentic communication in reducing…
The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy. The approval comes following a phase 3 EV-303 trial that…
Houston-based Memorial Hermann is teaming up with the Texas Medical Center’s Center for Device Innovation to nurture employee-driven innovation and help staff bring new ideas to life, the health system’s vice president of information technology and innovation told Becker’s. “From a…